Pakistan Drug Makers Vow Price Increases Lacking Import Costs Relief
This article was originally published in PharmAsia News
Executive SummaryPakistan's pharmaceutical industry is calling for relief from the government for the cost of raw materials they must import, threatening an increase in drug prices by as much as 20 percent
You may also be interested in...
Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.